Q-Line Biotec IPO
Allotment Status
Registrar: MUFG Intime India
Issue price
₹343
Listing price
₹452.005
Last GMP (₹)
₹101
GMP estimate
+29.45%
Actual listing gain
+31.78%
Return per lot
+₹43,602.16
GMP vs listing performance
GMP pointed to +29.45% but the stock listed at +31.78% — 2.3% higher than estimated.
Listing gain calculator
Estimate profit or loss based on actual listing performance
- Investment
- ₹1,37,200
- Listing value
- ₹1,80,802
- Listing gain
- +31.78%
- Profit (1 lot)
- +₹43,602
Based on issue price ₹343 × 400 shares per lot. Listing price ₹452. Excludes taxes, DP charges, and selling costs.
Listing results from exchange debut data where recorded. See GMP accuracy report · How we track this
Q-Line Biotec IPO — Quick Analysis
Q-Line Biotec IPO listed on 29 May 2026 at an issue price of ₹343, gained 31.8% on listing day. It delivered strong listing returns for allottees. The issue was subscribed 102.42x overall.
Overview
Q-Line Biotec is a recently listed SME IPO in India, raising ₹214.48 Cr, with shares offered around ₹343. The stock has listed with a +31.8% debut move versus the issue price. As an SME issue, expect a larger lot size and thinner post-listing liquidity than a typical Mainboard IPO.
GMP and subscription figures are unofficial market data, refreshed twice daily for active IPOs. Last updated 26 May 2026, 10:39 am IST. How we source data · Disclaimer
Strengths
- Subscribed 102.42x — strong demand.
- Positive GMP of ₹101 (+29.4%).
- Listed with +31.8% debut gain.
Risks
- Listing price can fall below issue price despite positive GMP.
- SME — higher lots, lower liquidity, more volatility.
- GMP is unofficial — not a confirmed listing outcome.
FAQ
Q-Line Biotec IPO questions
- What is Q-Line Biotec IPO price?
- ₹343 per share. Confirm in the RHP before applying.
- What is Q-Line Biotec IPO GMP?
- ₹101 (+29.4%). Unofficial — changes daily.
- When is Q-Line Biotec allotment?
- Expected around 26 May 2026. Check the registrar link on this page.